Alcohol alternatives – a goal for psychopharmacology?

@article{Nutt2006AlcoholA,
  title={Alcohol alternatives – a goal for psychopharmacology?},
  author={David J. Nutt},
  journal={Journal of Psychopharmacology},
  year={2006},
  volume={20},
  pages={318 - 320}
}
  • D. Nutt
  • Published 2006
  • Psychology, Medicine
  • Journal of Psychopharmacology
Drug misuse is the leading preventable cause of excess mortality and morbidity with tobacco being the main mortality culprit as it results in over 100000 deaths per year in the UK (Foresight, 2005). However alcohol is a growing problem worldwide that some believe may have already overtaken tobacco in terms of overall health and social care costs because of the consequences of intoxication, such as accidents, with subsequent medical complications (Room et al., 2005). Faced with the huge role of… Expand

Topics from this paper

Alcohol, ecstasy, Aldous Huxley’s ‘soma’
TLDR
David and I have broadly similar views on alcohol, since the authors are both aware of its damaging social and psychobiological effects, but they seem to have very different views on two other topics: the relative costs and dangers of using ecstasy/MDMA versus alcohol and whether it might be possible to develop a psychopharmacologically safe recreational drug. Expand
Doing it by numbers: A simple approach to reducing the harms of alcohol
TLDR
A new approach to reduce alcohol use and harms that would have major public health and social impacts is put forward, based on the assumption that heavy drinking is key. Expand
Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives
TLDR
It is submitted that aripiprazole would promote alcohol abstinence and reduce the alcohol seeking behaviour possibly via dopaminergic and serotoninergic modulations at the fronto-subcortical circuits underpinning alcohol reward and craving, impulsive behaviour as well as reduce alcohol-related anxiety/low mood and anhedonia. Expand
Ecstasy versus alcohol: Tolstoy and the variations of unhappiness
  • A. Parrott
  • Medicine
  • Journal of psychopharmacology
  • 2007
TLDR
The empirical evidence shows that MDMA is damaging in all of these areas; in relation to aggression, the acute administration of MDMA induces feelings of warmth and empathy in humans, and reduces aggressive behaviour in mice, but this pro-social period lasts for only a few hours. Expand
Preventing and Mitigating Alcohol Toxicity: A Review on Protective Substances
TLDR
It is impossible to fully prevent or mitigate toxicity effects by only the compounds in isolation, and further research is required to establish the long-term prevention and mitigation from the clinical point of view. Expand
Ethical issues in the treatment of addiction
Addiction or dependence to a psychoactive substance – or drug – is a biopsychosocial disorder. Many aspects of addiction can be clinically treated, yet this raises some important ethical issues. TheExpand
Low alcohol alternatives: a promising strategy for reducing alcohol related harm.
TLDR
Beer drinkers cannot readily distinguish low and regular strength beers and can enjoy socializing equally with either, and taxation strategies to create incentives for the manufacture, marketing and consumption of low alcohol alternatives are recommended. Expand
Emerging neurobiological treatments of addiction: ethical and public policy considerations
TLDR
This chapter identifies several ethical and social imperatives when considering the use of emerging neurotechnologies that are used with the primary aim of treating an individual, and are rigorously evaluated for safety and efficacy in the same way as other medical interventions. Expand
Physiology and pharmacology of alcohol: the imidazobenzodiazepine alcohol antagonist site on subtypes of GABAA receptors as an opportunity for drug development?
TLDR
The identification of a Ro15‐4513/EtOH binding site on unique GABAAR subtypes opens the possibility to characterize this alcohol site(s) and screen for compounds that modulate the function of EtOH/Ro15‐ 4513‐sensitive GABAARs. Expand
Long Term Effect of Ethanol on GABA-Benzodiazepine Receptors of Rat Brain Regions
Objective: The aim of this study is to investigate the effects of chronic exposure of ethanol ingestion on GABA benzodiazepine receptor complex in four rat brain regions. Methods: Male adult ratsExpand
...
1
2
...

References

SHOWING 1-10 OF 13 REFERENCES
Alcohol and public health
TLDR
Evidence suggests that treatment of alcohol-related problems should be incorporated into a public health response to alcohol problems, and that early intervention in primary care is feasible and effective, and a variety of behavioural and pharmacological interventions are available to treat alcohol dependence. Expand
Gamma hydroxy butyrate abuse and dependency
TLDR
GHB has been increasingly used in rape cases due to its capacity to produce intoxication and amnesia, and the management of patients dependent on GHB is rather complicated due to the high doses of medication that they require to control withdrawal symptoms. Expand
The clinical use of buprenorphine in opiate addiction: evidence and practice
TLDR
Buprenorphine cannot yet be considered the ‘gold standard’ treatment for opiate dependence because of the higher drop-out rates that may occur on induction using current techniques, its high-cost relative to methadone, and because the place of buprenorphines in treatment is still continuing to evolve. Expand
Anxiolytic Potential of Benzodiazepine Receptor Partial Agonists
TLDR
Animal studies suggest that partial agonists have less propensity to cause adverse effects, although they still retain anxiolytic properties, and several compounds are being developed and, although experience with them is limited, early clinical results appear promising. Expand
Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
TLDR
These guidelines primarily cover the pharmacological management of withdrawal, shortand longterm substitution, maintenance of abstinence and prevention of complications, where appropriate, in substance misuse, addiction and comorbidity with psychiatric disorders. Expand
Neurobiology of addiction and implications for treatment
TLDR
Understanding of the neuropharmacology of these disorders is increasing through the use of approaches such as neuroimaging and gene targeting and the availability of specific receptor agonists and antagonists. Expand
Hormonally regulated α4β2δ GABAA receptors are a target for alcohol
Here we report that low concentrations of alcohol (1–3 mM) increased Cl− currents gated by a recombinant GABAA receptor, α4β2δ, by 40–50% in Xenopus laevis oocytes. We also found greater hippocampalExpand
Making sense of GABAA receptor subtypes: is a new nomenclature needed?
  • D. Nutt
  • Chemistry, Medicine
  • Journal of psychopharmacology
  • 2005
TLDR
The phylogeny and inter-relations of many receptors and, for those linked to G-proteins, the classification systems used for a number of years appear to be adequate, albeit that regional brain variations in alternate spliced variants sometimes need to be taken into account. Expand
Metabotropic glutamate receptors as novel targets for anxiety and stress disorders
TLDR
These studies indicate that metabotropic glutamate receptors are interesting new targets to treat anxiety disorders in humans. Expand
Gammahydroxybutyrate (GHB) abuse and dependency
  • Journal of Psychopharmacology
  • 2005
...
1
2
...